 prospect evalu ciprofloxacin versu piperacillin amikacin empir antibiot therapi febril granulocytopen cancer patient lymphoma solid tumor european organ research treatment cancer intern antimicrobi therapi cooper group empir therapi febril granulocytopen patient mandatori monotherapi safe altern fluoroquinolon use agent indic controversi issu use monotherapi intraven ciprofloxacin mg therapi piperacillin amikacin febril granulocytopen patient solid tumor lymphoma studi patient ciprofloxacin overal success rate patient piperacillin amikacin patient versu patient patient gram-posit coccal bacteremia poor outcom therapi patient ciprofloxacin therapi none patient piperacillin amikacin death primari infect protocol therapi patient ciprofloxacin piperacillin amikacin studi use dose intraven ciprofloxacin empir monotherapi fever granulocytopen patient